Hot Products

Danshenxinkun A
Catalog No: CFN90325

Danshenxinkun A, Danshenxinkun B and Neocryptotanshinone may intervene thrombotic diseases by adjusting the targets mainly involved in pathways of endocrine system, signal transduction, signaling molecules and interaction, cell motility, environmental adaptation and nervous system. Oleoyl danshenxinkun A also selectively inhibits rabbit platelet aggregation induced by arachidonic acid.
Danshenxinkun B
Catalog No: CFN90326

Danshenxinkun B has antioxIdant activity, it may have the potential of being used as natural antioxidants in foods and cosmetics.
Danshenxinkun C
Catalog No: CFN90327

Reference standards.
Danshenxinkun D
Catalog No: CFN90328

Danshenxinkun D has antituberculosis H_(37)Rv activity in vitro.
Dantron
Catalog No: CFN99271

Danthron is an organic substance. It used to be a laxatica and now is currently used as an antioxidant in synthetic lubricants, in the synthesis of experimental antitumor agents, as a fungicide and as an intermediate for making dyes.Dantron can cause a significant reduction in the growth rate of Earthworms, it has potentially dangerous to the soil ecosystem.
Dapagliflozin
Catalog No: CFN60419

Daphnetin
Catalog No: CFN99952

Daphnetin is a dihydroxycoumarin that is being used in China for the treatment of coagulation disorders, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit antimalarial, anti-rheumatoid arthritis, anti-proliferative, anti-inflammatory and anti-oxidant activities. it is also a chelator and an antioxidant. Daphnetin can enhance immunological functions of B lymphocytes, the expression of IL-12 in B lymphocytes can be up-regulated by daphnetin through natural immunity approach.
Daphnetin 7-methyl ether
Catalog No: CFN90593

Daphnetin 7-methyl ether has anti-inflammatory activity.
Daphnezomine B
Catalog No: CFN98270

Reference standards.
Daphnin
Catalog No: CFN80132

Daphnin can contribute to the allergic potential of chamomile.